Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Generic Pharmaceuticals Wave 13

Atamis Ltd

This public procurement record has 5 releases in its history.

AwardUpdate

03 Aug 2022 at 08:38

Award Notice
AwardUpdate

03 Aug 2022 at 08:35

Award Notice
AwardUpdate

27 Jul 2022 at 12:35

Award Notice
Award

22 Jul 2022 at 15:53

Award Notice
Award

20 Jan 2022 at 12:23

Award Notice
Summary of the contracting process

The procurement process concerns the "NHS National Generic Pharmaceuticals Wave 13," facilitated by ATAMIS LTD based in Runcorn, UK. This open procurement, classified under pharmaceutical products, is currently in the award stage following its completion. The framework agreement has a duration of up to 28 months, with possibilities for extension extending to a total of 48 months. The effective contract period runs from 1 February 2022 to 31 May 2024. Key delivery regions include England and several associated territories such as Guernsey, Jersey, and the Isle of Man, with a total value of £469,741,550.

This tender presents substantial growth opportunities for businesses in the pharmaceutical sector, particularly those specialising in generic medications and related healthcare products. Small and medium enterprises (SMEs), especially those capable of fulfilling the diverse regional demands, are well-suited to compete. The open nature of the tender allows for a broad array of suppliers to engage, making it an attractive proposition for both established and emerging companies in the pharmaceutical market.

How relevant is this notice?

Notice Information

Notice Title

NHS National Generic Pharmaceuticals Wave 13

Notice Description

Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Transition (Everolimus) CESW: 1 March 2022 - 30 September 2023 (19 months) LSNE: 1 March 2022 - 31 January 2023 (11 months) NWLN: 1 March 2022 - 31 January 2023 (11 months) Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 (27 months) Hospital Only Products CESW: 1 February 2022 - 30 September 2023 (20 months) LSNE: 1 February 2022 - 31 May 2024 (28 months) NWLN: 1 February 2022 - 31 January 2023 (12 months)

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-7ded634b-6b01-4af7-afda-87458f7f80be
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/f872d76f-37e6-4b7e-b25e-c952ac8a42eb
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (below threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£469,741,550 £100M-£1B
Lots Value
Not specified
Awards Value
£939,483,069 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
3 Aug 20224 years ago
Submission Deadline
26 Jul 2021Expired
Future Notice Date
Not specified
Award Date
30 Nov 20214 years ago
Contract Period
1 Feb 2022 - 31 May 2024 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Atamis Ltd
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
132
Supplier Names

Atnahs Pharma UK Ltd

Chiesi Limited

Correvio GmbH

Flynn Pharma Ltd

Focus Pharmaceuticals Ltd

Galen Ltd

Recordati Pharmaceuticals Ltd

Takeda UK Limited

Tillomed Laboratories ltd

Upjohn UK Limited

Waymade PLC

Alturix

Beaumont Pharma Ltd

Clydesdale Pharma ltd

Euro-Link Pharma Ltd

Intrapharm Laboratories Ltd

Ipca Laboratories UK Ltd

Medley Pharma Ltd

mibe Pharma UK Ltd

Necessity Supplies Limited

Northumbria Pharma Limited

Noumed Life sciences

Oralieve UK Ltd

P M Pharma

Panpharma UK Limited

Phoenix Lab

Sciecure Pharma Limited

Sintetica Ltd

Swedish Orphan Biovitrum Ltd

Tetris Pharma Ltd

Transdermal Limited

Vantage Pharmaceuticals Ltd

Pfizer Ltd

Merck Sharpe & Dohme (UK) Limited

Allergan

Medreich PLC

Ennogen Healthcare Ltd

GlaxoSmithKline UK Limited

Syri Limited (T/A Thame Laboratories)

hameln pharma ltd

medac Pharma LLP

Martindale Pharma

Rosemont Pharmaceuticals Ltd

Mercury Pharmaceuticals Ltd

Selective Supplies Ltd

Nexcape Pharmaceuticals Ltd.

Consilient Health Ltd

Sandoz Ltd

Fresenius Kabi Limited

Glenmark Pharmaceuticals Europe Ltd

Laboratorio Reig Jofre SA

Kent Pharma Ltd

Bowmed Ibisqus Limited

Kensington Pharma Ltd

Healthcare Pharma Ltd

THORNTON & ROSS LIMITED

Mylan

Macleods Pharma UK Limited

Wockhardt UK Limited

Thea Pharmaceuticals Limited

Dr Falk Pharma UK Ltd

Desitin Pharma Ltd

Stragen UK Ltd

B. Braun Medical Limited

Torrent Pharma UK Ltd

Fontus Health Ltd

Aspire Pharma Ltd

Teva UK Limited

Amarox Limited

AOP Orphan Ltd

PIERRE FABRE LIMITED

Macure Pharma ApS

Ranbaxy (UK) Ltd

Arcadia Pharma Ltd T/A Arcadia Medical

Derma UK

Zista Pharma Ltd

Dr.Reddy's Laboratories (UK) Limited

Aspen Pharmacare UK Limited

Manx Healthcare Ltd

Colonis Pharma Ltd

Roche Products Ltd

Waverley Pharma Europe Limited

Profile Pharma Ltd

Reckitt Benckiser

Zentiva Pharma UK Ltd

Baxter Healthcare Ltd

Organon Pharmaceuticals UK Ltd

Day Lewis Medical Ltd

LogixX Pharma Ltd

Lundbeck Limited

Napp Pharmaceuticals Ltd

Bayer Plc

Recordati Rare Diseases UK Ltd

Morningside Pharmaeuticals

Dexcel Pharma Ltd

CST Pharma Limited

Cipla (EU) Limited

Flexipharm Austrading Limited

Relonchem Ltd

LEO Pharma

Aguettant Ltd

Torbay Pharmaceuticals

RPH Pharmaceuticals AB

Drugsrus Ltd

Ferring Pharmaceuticals Ltd

Milpharm Ltd/aurobinbdo

PARI

Crescent Pharma Limited

Roma Pharmaceuticals Limited

Kyowa Kirin Ltd

Brown & Burk UK Ltd

Seacross Pharmaceuticals Ltd

Lupin Healthcare UK Ltd

Alliance Pharmaceuticals Limited

Bristol Laboratories Limited

Aristo Pharma Limited

Synchrony

Alissa Healthcare Research Limited

Altan Pharma Ltd

Lucane Pharma

Norgine Pharmaceuticals Limited

Neon Healthcare Ltd

AVENTIS PHARMA LIMITED t-a Sanofi

MIP Pharma GmbH

Accord-UK Ltd

ACIUM LTD

Ascend Laboratories UK Ltd

Rivopharm UK Ltd

Strides Pharma Uk LTD

V Pharma

Ferndale Pharmaceuticals Ltd

Typharm Ltd

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...